Роль предменструального дисфорического расстройства в формировании риска после­родовой депрессии: эпидемиологические и нейробио­логические аспекты

1. Shorey S., Chee C.Y.I., Ng E.D., Chan Y.H., Tam W.W.S., Chong Y.S. Prevalence and incidence of postpartum depression among healthy mothers: ф systematic review and meta-analysis. J. Psychiatr. Res. 2018; 104: 235-48. https://dx.doi.org/10.1016/j.jpsychires.2018.08.001
2. Hahn-Holbrook J., Cornwell-Hinrichs T., Anaya I. Economic and health predictors of national postpartum depression prevalence: a systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries. Front. Psychiatry. 2018; 8: 248. https://dx.doi.org/10.3389/fpsyt.2017.00248
3. Chan K., Rubtsova A.A., Clark C.J. Exploring diagnosis and treatment of premenstrual dysphoric disorder in the U.S. healthcare system: a qualitative investigation. BMC Women’s Health. 2023; 23: 272. https://dx.doi.org/10.1186/s12905-023-02334-y
4. Islas-Preciado D., Ramos-Lira L., Estrada-Camarena E. Unveiling the burden of premenstrual dysphoric disorder: a narrative review to call for gender perspective and intersectional approaches. Front. Psychiatry. 2025; 15: 1458114. https://dx.doi.org/10.3389/fpsyt.2024.1458114
5. Hodgetts S., Kinghorn A. Examining the impact of premenstrual dysphoric disorder (PMDD) on life and relationship quality: an online cross-sectional survey study. PLoS One. 2025; 20(4): e0322314. https://dx.doi.org/10.1371/journal.pone.0322314
6. Slomian J., Honvo G., Emonts P., Reginster J.Y., Bruyère O. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Women’s Health (Lond). 2019; 15: 1745506519844044. https://dx.doi.org/10.1177/1745506519844044
7. Стеняева Н.Н., Пекарева Н.А., Зубков В.В., Хритинин Д.Ф. Гипогалактия и послеродовая депрессия. Акушерство и гинекология. 2025; 1: 127-32 https://dx.doi.org/10.18565/aig.2025.12 [Stenyaeva N.N., Pekareva N.A., Zubkov V.V., Khritinin D.F. Hypogalactia and postpartum depression. Obstetrics and Gynecology. 2025; (1): 127-32 (in Russian). https://dx.doi.org/10.18565/aig.2025.12].
8. Howard L.M., Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry. WPA. 2020; 19(3): 313-27. https://dx.doi.org/10.1002/wps.20769
9. Epperson C.N., Huang M.Y., Cook K., Gupta D., Chawla A., Greenberg P.E. Healthcare resource utilization and costs associated with postpartum depression among commercially insured households. Curr. Med. Res. Opin. 2020; 36(10): 1707-16. https://dx.doi.org/10.1080/03007995.2020.1799772
10. Yim I.S., Tanner Stapleton L.R., Guardino C.M., Hahn-Holbrook J., Dunkel Schetter C. Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. Annu. Rev. Clin. Psychol. 2015; 11(1): 99-137. https://dx.doi.org/10.1146/annurev-clinpsy-101414-020426
11. O’Hara M.W., McCabe J.E. Postpartum depression: current status and future directions. Annu. Rev. Clin. Psychol. 2013; 9(1): 379-407. https://dx.doi.org/10.1146/annurev-clinpsy-050212-185612
12. Acoba E.F. Social support and mental health: the mediating role of perceived stress. Front. Psychol. 2024; 15: 1330720. https://dx.doi.org/10.3389/fpsyg.2024.1330720
13. Hantsoo L., Payne J.L. Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA. Neurosci. Biobehav. Rev. 2023; 149: 105168. https://dx.doi.org/10.1016/j.neubiorev.2023.105168
14. Ohsuga T., Egawa M., Tsuyuki K., Ueda A., Komatsu M., Chigusa Y. et al. Association of preconception premenstrual disorders with perinatal depression: an analysis of the perinatal clinical database of a single Japanese institution. Biopsychosoc. Med. 2024; 18: 24. https://dx.doi.org/10.1186/s13030-024-00323-7
15. Markenson G.R., Saade G.R., Laurent L., Heyborne K., Coonrod D.V., Schoen C.N. Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. Am. J. Obstet. Gynecol. MFM. 2020; 2(3): 100140. https://dx.doi.org/10.1016/j.ajogmf.2020.100140
16. Mishra S., Elliott H., Marwaha R. Premenstrual Dysphoric Disorder. StatPearls. Treasure Island (FL): StatPearls Publishing, 2025.
17. Pataki B., Kiss B.L., Kálmán S., Kovács I. Premenstrual dysphoric disorder - an undervalued diagnosis? A cross-sectional study in Hungarian women. Compr. Psychoneuroendocrinol. 2024; 20: 100256. https://dx.doi.org/10.1016/j.cpnec.2024.100256
18. Mu E., Chiu L., Kulkarni J. Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression. Front. Pharmacol. 2025; 16: 1528544. https://dx.doi.org/10.3389/fphar.2025.1528544
19. Cao S., Jones M., Tooth L., Mishra G. Does premenstrual syndrome before pregnancy increase the risk of postpartum depression? Findings from the Australian longitudinal study on women’s health. J. Affect. Disord. 2021; 279: 143-8. https://dx.doi.org/10.1016/j.jad.2020.09.130
20. Amiel Castro R.T., Pataky E.A., Ehlert U. Associations between premenstrual syndrome and postpartum depression: a systematic literature review. Biol. Psychol. 2019; 147(1): 107612. https://dx.doi.org/10.1016/j.biopsycho.2018.10.014
21. Reilly T.J., Patel Sh., Unachukwu I., Knox C.L., Craig M.C. et al. The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis. J. Affect. Disord. 2024; 349: 534-40. https://dx.doi.org/10.1016/j.jad.2024.01.066
22. Pereira D., Pessoa A.R., Madeira N., Macedo A., Pereira A.T. Association between premenstrual dysphoric disorder and perinatal depression: a systematic review. Arch. Women’s Ment. Health. 2022; 25(1): 61-70. https://dx.doi.org/10.1007/s00737-021-01177-6
23. Gastaldon C., Solmi M., Correll C.U., Barbui C., Schoretsanitis G. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. Br. J. Psychiatry. 2022; 221(4): 591-602. https://dx.doi.org/10.1192/bjp.2021.222
24. Bengi D., Strawbridge R., Drorian M., Juruena M.F., Young A., Frey B.N. A systematic review and meta-analysis on the comorbidity of premenstrual dysphoric disorder or premenstrual syndrome with mood disorders: prevalence, clinical and neurobiological correlates. Br. J. Psychiatry. 2025; 1-14. https://dx.doi.org/10.1192/bjp.2025.133
25. Amiel Castro R.T., Pataky E.A., Ehlert U. Associations between premenstrual syndrome and postpartum depression: a systematic literature review. Biological. Psychology. 2019; 147: 107612. https://dx.doi.org/10.1016/j.biopsycho.2018.10.014
26. Legesse D.H., Fan C., Teng J., Zhuang Y., Howard R.J., Noviello C.M. Structural insights into opposing actions of neurosteroids on GABAA receptors. Nat. Commun. 2023; 14(1): 5091. https://dx.doi.org/10.1038/s41467-023-40800-1
27. Gao Q., Sun W., Wang Y.R., Li Z.F., Zhao F., Geng X.W. et al. Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: toward precise targets for translational medicine and drug development. Front. Psychiatry. 2023; 14: 1140796. https://dx.doi.org/10.3389/fpsyt.2023.1140796
28. Osborne L.M., Betz J.F., Yenokyan G., Standeven L.R., Payne J.L. The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms. Front. Psychol. 2019; 10: 1033. https://dx.doi.org/10.3389/fpsyg.2019.01033
29. Maguire J. Neuroactive steroids and GABAergic involvement in the neuroendocrine dysfunction Associated with major depressive disorder and postpartum depression. Front. Cell. Neurosci. 2019; 13: 83. https://dx.doi.org/10.3389/fncel.2019.00083
30. Meltzer-Brody S., Kanes S.J. Allopregnanolone in postpartum depression: role in pathophysiology and treatment. Neurobiol. Stress. 2020; 12: 100212. https://dx.doi.org/10.1016/j.ynstr.2020.100212
31. Sacher J., Zsido R.G., Barth C., Zientek F., Rullmann M., Luthardt J. et al. Increase in serotonin transporter binding in patients with premenstrual dysphoric disorder across the menstrual cycle: a case-control longitudinal neuroreceptor ligand positron emission tomography imaging study. Biol. Psychiatry. 2023; 93(12): 1081-8. https://dx.doi.org/10.1016/j.biopsych.2022.12.023
32. Hamidovic A., Davis J., Soumare F. Blunted cortisol response to acute psychosocial stress in women with premenstrual dysphoric disorder. Int. J. Neuropsychopharmacol. 2024; 27(3): pyae015. https://dx.doi.org/10.1093/ijnp/pyae015
33. Niwa M., Lockhart S., Wood D.J., Yang K., Francis-Oliveira J., Kin K. et al. Prolonged HPA axis dysregulation in postpartum depression associated with adverse early life experiences: a cross-species translational study. Nat. Ment. Health. 2024; 2(5): 593-604. https://dx.doi.org/10.1038/s44220-024-00217-1
34. Soares C.J., Faria-e-Silva A.L., de Paula Rodrigues M., Vilela A.B.F., Pfeifer C.S., Tantbirojn D. et al. Polymerization shrinkage stress of composite resins and resin cements – what do we need to know? Braz. Oral Res. 2017; 31(1): e62. https://dx.doi.org/10.1590/1807-3107bor-2017.vol31.0062
35. Schiller C.E., Johnson S.L., Abate A.C., Schmidt P.J., Rubinow D.R. Reproductive steroid regulation of mood and behavior. Compr. Physiol. 2016; 6(3): 1135-60. https://dx.doi.org/10.1002/cphy.c150014
36. Wei S.M., Wakim P., Martinez P.E., Nieman L.K., Rubinow D.R., Schmidt P.J. Differential effects of ovarian steroids in women with and without premenstrual dysphoric disorder: a replication and extension of findings. Am. J. Psychiatry. 2025; 182(10): 922-34. https://dx.doi.org/10.1176/appi.ajp.2025.0505
37. Eisenlohr-Moul T.A., Bowers S.M., Prinstein M.J., Schmalenberger K.M., Walsh E.C., Young S.L. Effects of acute estradiol and progesterone on perimenstrual exacerbation of suicidal ideation and related symptoms: a crossover randomized controlled trial. Transl. Psychiatry. 2022; 12: 528. https://dx.doi.org/10.1038/s41398-022-02294-1
38. Schoretsanitis G., Osborne L.M., Sundström-Poromaa I., Wenzel E.S., Payne J.L., Barbui C. et al. Peripartum allopregnanolone blood concentrations and depressive symptoms: a systematic review and individual participant data meta-analysis. Mol. Psychiatry. 2025; 30(3): 1148-60. https://dx.doi.org/10.1038/s41380-024-02747-7
39. Arora A., Chakraborty S., Pandey R. Understanding premenstrual dysphoric disorder from a psychosomatic and a sensory perspective. Front. Glob. Womens Health. 2025; 6: 1595083. https://dx.doi.org/10.3389/fgwh.2025.1595083
40. Tiranini L., Nappi R.E. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Fac. Rev. 2022; 11: 11. https://dx.doi.org/10.12703/r/11-11
41. Islas-Preciado D., Estrada-Camarena E., Galea L.A.M. Menstrually-related mood disorders and postpartum depression: Convergent aspects in aetiology. Front. Neuroendocrinol. 2025; 76: 101171. https://dx.doi.org/10.1016/j.yfrne.2024.101171
42. Schleimann-Jensen E., Sundström-Poromaa I., Meltzer-Brody S., Eisenlohr-Moul T.A., Papadopoulos F.C., Skalkidou A. et al. Trajectories and dimensional phenotypes of depressive symptoms throughout pregnancy and postpartum in relation to prior premenstrual symptoms. Br. J. Psychiatry. 2025; 226(6): 401-9. https://dx.doi.org/10.1192/bjp.2025.38
43. Lambert E., Hunter M., Cocker H., Gurvich C., Chalder T. Emotion regulation in premenstrual dysphoric disorder and premenstrual syndrome: a systematic review. BMC Psychol. 2025; 13: 1289. https://dx.doi.org/10.1186/s40359-025-03587-y

Поступила 19.03.2026

Принята в печать 09.07.2026